TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
53.53
+0.05 (0.09%)
At close: Jul 30, 2026, 4:00 PM EDT
53.43
-0.10 (-0.19%)
After-hours: Jul 30, 2026, 7:44 PM EDT
TG Therapeutics Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, TG Therapeutics stock has a consensus rating of "Buy" and an average price target of $68.43. The average 1-year stock price forecast is 27.83% higher than the current stock price, while the lowest is $20 (-62.64%) and the highest is $86 (+60.66%).
Price Target: $68.43 (+27.83%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TG Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Maintains $55 → $86 | Buy | Maintains | $55 → $86 | +60.66% | Jul 27, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $50 → $75 | Buy | Maintains | $50 → $75 | +40.11% | Jul 21, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $65 | Buy | Maintains | $65 | +21.43% | Jul 16, 2026 |
| Jefferies | Jefferies | Buy Maintains $83 | Buy | Maintains | $83 | +55.05% | Jul 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $70 → $77 | Buy | Maintains | $70 → $77 | +43.84% | Jul 13, 2026 |
Financial Forecast
Revenue This Year
942.51M
from 616.29M
Increased by 52.93%
Revenue Next Year
1.29B
from 942.51M
Increased by 37.13%
EPS This Year
1.57
from 2.77
Decreased by -43.24%
EPS Next Year
3.28
from 1.57
Increased by 108.67%
EPS and Forward PE are based on non-GAAP adjusted numbers.